Vendor
Evolve BioPep
Across every vendor we track, they are the cheapest on 0 of 29 compounds and above typical on 4.
- Listings
- 32
- In the index
- 292 queued
- Last checked
- 13 Oct 2026
- Recheck due
- Every 24 h
In the price index
Their wording, our reading, and how it compares
| Compound | As they list it | Price | Per mg | Vs other vendors |
|---|---|---|---|---|
| SLU-PP-332100 mg × 120 · capsules | SLU-PP-332 100MG X120 | $220.00 | $0.018 | Not compared |
| 5-Amino-1MQ50 mg × 60 · capsules | 5-AMINO-1MQ 50MG X60 | $100.00 | $0.033 | Not compared |
| NAD+350 mg | NAD+ NICOTINAMIDE 350MG | $30.00 | $0.086 | Below typicalof 65 |
| SNAP-8200 mg · raw powder | SNAP 8 200MG RAW POWDER | $35.00 | $0.175 | Not compared |
| GHK-Cu50 mg | GHK-CU 50MG COPPER TRIPEPTIDE | $30.00 | $0.600 | Typicalof 63 |
| GLOW70 mg | GLOW 70MG PEPTIDE RESEARCH | $65.00 | $0.929 | Below typicalof 41 |
| Tirzepatide60 mg | TIRZ-60|DUAL AGONIST 60MG | $100.00 | $1.67 | Below typicalof 33 |
| MOTS-c40 mg | MOTS-C 40MG | $85.00 | $2.13 | Below typicalof 59 |
| Tirzepatide30 mg | TIRZ-30|DUAL AGONIST 30MG | $80.00 | $2.67 | Below typicalof 33 |
| Epitalon10 mg | EPITALON 10MG RESEARCH PEPTIDE | $30.00 | $3.00 | Typicalof 51 |
| Afamelanotide10 mg | MELANOTAN-1 10MG | $30.00 | $3.00 | Below typicalof 23 |
| Melanotan II10 mg | MELANOTAN-2 10MG | $30.00 | $3.00 | Below typicalof 46 |
| MOTS-c10 mg | MOTS-C 10MG | $30.00 | $3.00 | Below typicalof 59 |
| PT-14110 mg | PT-141 10MG | $30.00 | $3.00 | Below typicalof 49 |
| Wolverine20 mg | BPC/TB500(10/10MG) WOLVERINE | $65.00 | $3.25 | Below typicalof 52 |
| BPC-15710 mg | BPC-157 10mg | $35.00 | $3.50 | Below typicalof 59 |
| KPV10 mg | KPV 10MG(LYSINE-PROLINE-VALINE) | $35.00 | $3.50 | Below typicalof 52 |
| Selank10 mg | SELANK NEUROPEPTIDE 10MG | $35.00 | $3.50 | Below typicalof 46 |
| Semax10 mg | SEMAX NEUROPEPTIDE 10MG | $35.00 | $3.50 | Below typicalof 47 |
| Wolverine10 mg | BPC/TB500(5/5MG) WOLVERINE | $40.00 | $4.00 | Below typicalof 52 |
| Tirzepatide15 mg | TIRZ-15|DUAL AGONIST 15MG | $65.00 | $4.33 | Above typicalof 33 |
| CJC-1295 / Ipamorelin10 mg | CJC-1295(NODAC)IPAMORELIN GHROUTE 5/5MG | $50.00 | $5.00 | Below typicalof 35 |
| TB-50010 mg | TB500 THYMOSIN BETA4 10MG | $50.00 | $5.00 | Below typicalof 40 |
| Tirzepatide5 mg | TIRZ-05|DUAL AGONIST 5MG | $30.00 | $6.00 | Above typicalof 33 |
| Tesamorelin / Ipamorelin13 mg | TESARAK TESA/IPA 10/3MG | $80.00 | $6.15 | Below typicalof 23 |
| Tesamorelin10 mg | TESAMORELIN 10MG | $65.00 | $6.50 | Typicalof 49 |
| DSIP5 mg | DSIP 5MG RESEARCH PEPTIDE | $35.00 | $7.00 | Above typicalof 48 |
| KLOW10 mg | KLOWτm 10MG MULTI-PEPTIDE | $80.00 | $8.00 | Above typicalof 39 |
| Cagrilintide5 mg | CAGRI 5MG RESEARCH PEPTIDE | $45.00 | $9.00 | Below typicalof 31 |
Prices are what the vendor listed when we last looked, not a live quote. Comparisons are per milligram against the median across every vendor we track. Outbound links carry no affiliate parameters.
Read, but not published
A listing counts toward the index only once the size and count are certain — a guess about whether “10 x 10mg” means 10 mg or 100 mg is a tenfold error. These are shown because hiding them would make the catalogue look smaller than it is.
- X-10 VIALS KIT TIRZ 30MGAwaiting review$500.00
- EVOTRIVITA BLEND X60Not attributed to a compound$150.00
TermsListing is not endorsement. We take no payment for inclusion or position, hold no affiliate relationship with any seller, and have not tested what is in their vials. Batch disclosure is a signal about process, not a guarantee about contents.
Assessing a vendor yourself
A price is one signal, and not the important one. The method matters more than any verdict we could give you.
Next
Is this a good price?
- Every compound we priceWhere Evolve BioPep's listings sit against every other seller we read, per milligram, so vial sizes compare.
- Which way prices are movingA quiet fifteen per cent rise is invisible in today's number and obvious across the last few weeks.
- The rest of the directoryThe other sellers we track, what each stocks, and how recently we last read their catalogue.